Alpine Immune Sciences (ALPN) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free ALPN Stock Alerts $64.94 +0.12 (+0.19%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alpine Immune Sciences Short Interest DataCurrent Short Volume3,890,000 sharesPrevious Short Volume4,740,000 sharesChange Vs. Previous Month-17.93%Dollar Volume Sold Short$251.26 millionShort Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares65,560,000 sharesPercentage of Shares Shorted5.93%Today's Trading Volume3,047,933 sharesAverage Trading Volume2,210,169 sharesToday's Volume Vs. Average138% Short Selling Alpine Immune Sciences ? Sign up to receive the latest short interest report for Alpine Immune Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALPN Short Interest Over TimeALPN Days to Cover Over TimeALPN Percentage of Float Shorted Over Time Ad Banyan Hill PublishingCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Alpine Immune Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,890,000 shares $251.26 million -17.9%N/A1.7 $64.59 4/15/20244,740,000 shares $305.35 million -10.2%N/A2.1 $64.42 3/31/20245,280,000 shares $209.30 million -5.9%N/A4.4 $39.64 3/15/20245,610,000 shares $204.09 million +26.6%N/A5.1 $36.38 2/29/20244,430,000 shares $156.02 million +9.9%N/A4.4 $35.22 2/15/20244,030,000 shares $120.42 million +20.7%N/A4.3 $29.88 Get the Latest News and Ratings for ALPN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,340,000 shares $88.88 million +38.6%N/A3.6 $26.61 1/15/20242,410,000 shares $49.28 million -39.5%N/A3.1 $20.45 12/31/20233,980,000 shares $75.86 million +32.7%N/A5 $19.06 12/15/20233,000,000 shares $56.70 million -9.6%N/A4 $18.90 11/30/20233,320,000 shares $51.46 million -23.7%N/A5.1 $15.50 11/15/20234,350,000 shares $54.94 million +51.0%N/A7.5 $12.63 10/31/20232,880,000 shares $29.49 million +31.5%N/A5.6 $10.24 10/15/20232,190,000 shares $22.47 million -21.8%N/A6.8 $10.26 9/30/20232,800,000 shares $32.06 million +6.9%N/A11 $11.45 9/15/20232,620,000 shares $32.93 million +4.0%N/A11.3 $12.57 8/31/20232,520,000 shares $31.12 million +28.6%N/A10.8 $12.35 8/15/20231,960,000 shares $26.46 million +31.5%N/A8.9 $13.50 7/31/20231,490,000 shares $18.68 million +0.7%N/A6.5 $12.54 7/15/20231,480,000 shares $16.32 million -3.3%N/A7.8 $11.03 6/30/20231,530,000 shares $15.73 million +26.5%N/A8.9 $10.28 6/15/20231,210,000 shares $13.19 million +1.7%N/A7.2 $10.90 5/31/20231,190,000 shares $11.85 million +3.5%N/A10.3 $9.96 5/15/20231,150,000 shares $9.97 million +8.5%N/A10.7 $8.67 4/30/20231,060,000 shares $7.94 million +1.9%N/A14.8 $7.49 4/15/20231,040,000 shares $7.60 million -1.0%N/A13.3 $7.31 3/31/20231,050,000 shares $8.11 million +17.6%N/A12.5 $7.72 3/15/2023892,900 shares $7.18 million +10.8%N/A9.7 $8.04 2/28/2023805,900 shares $6.42 million +8.7%N/A7.5 $7.97 2/15/2023741,100 shares $6.24 million -2.8%N/A6.7 $8.42 1/31/2023762,700 shares $6.41 million -6.6%N/A6.7 $8.40 1/15/2023816,200 shares $7.14 million -65.0%N/A6.6 $8.75 12/30/20222,330,000 shares $17.13 million -0.4%N/A19 $7.35 12/15/20222,340,000 shares $15.28 million +6.4%N/A18.4 $6.53 11/30/20222,200,000 shares $13.82 million +4.3%N/A19.4 $6.28 11/15/20222,110,000 shares $13.19 million +11.6%N/A19.4 $6.25 10/31/20221,890,000 shares $11.17 million +2.7%N/A19.5 $5.91 10/15/20221,840,000 shares $13.06 million +12.9%N/A20.2 $7.10 9/30/20221,630,000 shares $11.74 million +19.0%N/A20.7 $7.20 9/15/20221,370,000 shares $11.10 million -2.1%7.0%17.6 $8.10“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. ALPN Short Interest - Frequently Asked Questions What is Alpine Immune Sciences' current short interest? Short interest is the volume of Alpine Immune Sciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,890,000 shares of ALPN short. Learn More on Alpine Immune Sciences' current short interest. What is a good short interest ratio for Alpine Immune Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPN shares currently have a short interest ratio of 2.0. Learn More on Alpine Immune Sciences's short interest ratio. Which institutional investors are shorting Alpine Immune Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alpine Immune Sciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Alpine Immune Sciences' short interest increasing or decreasing? Alpine Immune Sciences saw a drop in short interest in April. As of April 30th, there was short interest totaling 3,890,000 shares, a drop of 17.9% from the previous total of 4,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Alpine Immune Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Alpine Immune Sciences: Perrigo Company plc (2.55%), Alkermes plc (7.62%), Nuvalent, Inc. (20.08%), Insmed Incorporated (5.74%), Madrigal Pharmaceuticals, Inc. (18.70%), Crinetics Pharmaceuticals, Inc. (6.24%), Summit Therapeutics Inc. (28.19%), Biohaven Ltd. (10.91%), Axsome Therapeutics, Inc. (16.23%), Ultragenyx Pharmaceutical Inc. (5.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Alpine Immune Sciences stock? Short selling ALPN is an investing strategy that aims to generate trading profit from Alpine Immune Sciences as its price is falling. ALPN shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alpine Immune Sciences? A short squeeze for Alpine Immune Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPN, which in turn drives the price of the stock up even further. How often is Alpine Immune Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PRGO Short Interest Data ALKS Short Interest Data NUVL Short Interest Data INSM Short Interest Data MDGL Short Interest Data CRNX Short Interest Data SMMT Short Interest Data BHVN Short Interest Data AXSM Short Interest Data RARE Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALPN) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings